Tuesday, May 13, 2025

Latest:

Dr. Margaret Goodell elected to the National Academy of Sciences
Healthy Habits: Dr. Samer Mattar enjoys walking on the treadmill
Urogynecology and Urology: What’s the difference?
A combined computational and experimental approach uncovered promising genetic players in Alzheimer’s disease
Healthy Habits: Group workouts motivate Dr. Jordana Faruqi

Home
Momentum
From The Labs
- About From the Labs
- Follow From The Labs on Twitter
Policywise
- About PolicyWise
- Follow @BCMEthics on Twitter
The Stitch
- About The Stitch
Progress Notes
bcm.edu

MYCN

From The Labs

Researchers identify an Achilles’ heel in neuroblastoma

August 16, 2022 cancer treatment, FATP2, fatty acid metabolism, metabolimics, MYCN, neuroblastoma, Research

A metabolic vulnerability in neuroblastoma could be exploited to overturn these tumors’ resistance to therapy.

From The Labs

Turning the molecular clock back on halts neuroblastoma tumor growth

July 27, 2021 BMAL1, brain cancer, molecular clock, MYCN, neuroblastoma, Research, RORa

Restoring function of the molecular clock blocks tumor growth in advanced neuroblastoma and can make tumors more sensitive to conventional chemotherapy.

From the Labs: a closer look at metastatic medulloblastoma